Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Silgan (SLGN)

Silgan Q4 GAAP EPS falls to $0.42 while record adjusted EPS reaches $0.85

Mixed Impact 3 of 5 earnings Written later

Silgan reported fourth quarter and full year 2024 results on January 29, 2025. Q4 net sales rose 5% to $1.4 billion and adjusted diluted EPS rose 35% to $0.85, but GAAP net income fell to $45.1 million ($0.42 per diluted share) from $64.4 million ($0.60). The company expects 2025 adjusted diluted EPS of $4.00 to $4.20, which it says is a 13% increase at the midpoint over 2024.

Key points

  • Q4 2024 net sales $1.4 billion, up $71.1 million (5%), mainly from the Weener Packaging acquisition
  • Full year 2024 net income $276.4 million ($2.58 per diluted share) vs. $326.0 million ($2.98) in 2023; adjusted EPS $3.62 vs. $3.40
  • Q4 rationalization charges $21.4 million, tied to the announced restructuring program
  • 2025 guidance: adjusted diluted EPS $4.00 to $4.20; free cash flow approximately $450 million

The filing

CompanySilgan (SLGN)
Form8-K, current report
Filed with the SECJan 29, 2025, 4:30 PM ET
Accession number0000849869-25-000007

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:00 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on January 29, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.